Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Informations projet

BIOSIM

N° de convention de subvention: 778586

DOI

10.3030/778586

Projet clôturé

Date de signature de la CE 19 Septembre 2017

Date de début 1 Octobre 2017

Date de fin 31 Mai 2019

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total

€ 2 029 325,00

Contribution de l’UE

€ 2 029 325,00

Coordonné par

VALITACELL LTD
Ireland

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Demonstrators, pilots, prototypes (3)

CE marked product

Ensuring that Valitacell product and associated has the required CE registration

Peer reviewed publication submitted

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Publications

Peer reviewed articles (1)

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Auteurs: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Publié dans: Analytical Biochemistry, Numéro 534, 2017, Page(s) 49-55, ISSN 0003-2697
Éditeur: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Droits de propriété intellectuelle

Patent (9)

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numéro de demande/publication: EP 15718799
Date: 2015-04-02
Demandeur(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numéro de demande/publication: EP 15736411
Date: 2015-06-18
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Numéro de demande/publication: EP 14830805
Date: 2014-12-17
Demandeur(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numéro de demande/publication: EP 15736411
Date: 2015-06-18
Demandeur(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numéro de demande/publication: EP 15736411
Date: 2015-06-18
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numéro de demande/publication: EP 15718799
Date: 2015-04-02
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Numéro de demande/publication: EP 14830805
Date: 2014-12-17
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numéro de demande/publication: EP 15718799
Date: 2015-04-02
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Numéro de demande/publication: EP 14830805
Date: 2014-12-17
Demandeur(s): VALITACELL LTD

Trademark (3)

chemstress

Numéro de demande/publication: TM 017262511
Date: 2018-02-12
Demandeur(s): VALITACELL LTD

chemstress

Numéro de demande/publication: TM 017262511
Date: 2018-02-12
Demandeur(s): VALITACELL LTD

chemstress

Numéro de demande/publication: TM 017262511
Date: 2018-02-12
Demandeur(s): VALITACELL LTD